Literature DB >> 16184561

Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity.

Nanne K H de Boer, Chris J J Mulder, Adriaan A van Bodegraven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16184561     DOI： 10.1002/lt.20554

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

2.  Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.

Authors:  Ashish Goel; Banumathi Ramakrishna; Jayaprakash Muliyil; Kadiyala Madhu; K G Sajith; Uday Zachariah; Jeyamani Ramachandran; Shyamkumar N Keshava; R Selvakumar; George M Chandy; Elwyn Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

Review 3.  Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.

Authors:  Robert Hirten; Keith Sultan; Ashby Thomas; David E Bernstein
Journal:  World J Hepatol       Date:  2015-11-28

4.  Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.

Authors:  Linea Natalie Toksvang; Magnus Strøh Schmidt; Sofie Arup; Rikke Hebo Larsen; Thomas Leth Frandsen; Kjeld Schmiegelow; Cecilie Utke Rank
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.